Literature DB >> 39147

Central actions of valproate sodium.

M Schmutz, H R Olpe, W P Koella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 39147     DOI： 10.1111/j.2042-7158.1979.tb13538.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells.

Authors:  J M Godfraind
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate.

Authors:  R Wolf; U Tscherne; H M Emrich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

3.  Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro.

Authors:  H R Olpe; M W Steinmann; M F Pozza; F Brugger; M Schmutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

4.  The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.

Authors:  R W Kerwin; H R Olpe; M Schmutz
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  The role of different types of adrenergic receptors in pentylenetetrazol-induced seizures and the effect of di-n-propylacetate in the rat.

Authors:  M Lazarova; C Bendotti; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate.

Authors:  M Lazarova; C Bendotti; R Samanin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.